Published in AIDS Weekly, April 28th, 1997
The naturally occurring (beta)-chemokines RANTES, MIP-1(alpha), and MIP-1(beta) inhibit HIV infection by primary and macrophage-tropic HIV-1 isolates (Cocchi et al., Science, 1995;270:1811-5), but they cannot prevent infection of primary macrophage cultures. Moreover, their use as AIDS therapies is limited by their natural functions of leukocyte activation and chemotaxis signalling.
Now an international research team reports that a modification to one of these cytokines, RANTES, causes it to completely block the CCR5...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.